Moderna says Health Canada has approved its mRNA vaccine, shown in a handout photo, to protect against respiratory syncytial virus in adults age 60 and older. THE CANADIAN PRESS/HO-Moderna **MANDATORY CREDIT**
In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older. According to the Public Health Agency of Canada’s wastewater surveillance, the level of RSV circulating is currently “moderate” across much of the country.
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
แหล่ง: SooToday - 🏆 8. / 85 อ่านเพิ่มเติม »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
แหล่ง: BurnabyNOW_News - 🏆 14. / 77 อ่านเพิ่มเติม »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
แหล่ง: PGCitizen - 🏆 65. / 51 อ่านเพิ่มเติม »
Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
แหล่ง: globeandmail - 🏆 5. / 92 อ่านเพิ่มเติม »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
แหล่ง: timescolonist - 🏆 15. / 75 อ่านเพิ่มเติม »